​

Harrow Health (HROW) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

HROW Stock Forecast

Harrow Health (HROW) stock forecast, based on 9 Wall Street analysts, predicts a 12-month average price target of $73.00, with a high of $94.00 and a low of $64.00. This represents a 42.91% increase from the last price of $51.08.

$10 $27 $44 $61 $78 $95 High: $94 Avg: $73 Low: $64 Last Closed Price: $51.08

HROW Stock Rating

Harrow Health stock's rating consensus is Buy, based on 9 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 9 Buy (100.00%), 0 Hold (0.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 9 0 9 Strong Sell Sell Hold Buy Strong Buy

HROW Price Target Upside V Benchmarks

TypeNameUpside
StockHarrow Health42.91%
SectorHealthcare Stocks 15.45%
IndustrySpecialty & Generic Drug Manufacturers Stocks20.02%

Price Target Trends

1M3M12M
# Anlaysts-35
Avg Price Target-$76.00$73.60
Last Closing Price$51.08$51.08$51.08
Upside/Downside-48.79%44.09%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Dec, 25-8---8
Nov, 2517---8
Oct, 2517---8
Sep, 2517---8
Aug, 2517---8
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Nov 11, 2025Cantor Fitzgerald$94.00$38.74142.64%84.03%
Sep 29, 2025Thomas FlatenLake Street$70.00$47.1048.62%37.04%
Sep 23, 2025Chase KnickerbockerCraig-Hallum$64.00$48.9330.80%25.29%
Aug 13, 2025Yi ChenH.C. Wainwright$64.00$34.8383.75%25.29%
Jul 11, 2025Steve SeedhouseCantor Fitzgerald$76.00$34.93117.58%48.79%
Oct 18, 2024Sahil KazmiB.Riley Financial$73.00$56.4129.41%42.91%
Oct 04, 2024Brooks O'NeilLake Street$55.00$49.7510.55%7.67%
Aug 09, 2024Chase KnickerbockerCraig-Hallum$45.00$35.2527.66%-11.90%
Jun 21, 2024Chase KnickerbockerCraig-Hallum$30.00$19.9350.53%-41.27%
Jun 03, 2024Brooks O'NeilLoop Capital Markets$25.00$17.6841.40%-51.06%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Nov 11, 2025Cantor FitzgeraldOverweightOverweighthold
Oct 01, 2025B. RileyBuyBuyhold
Sep 29, 2025Lake StreetBuyBuyhold
Sep 23, 2025Craig-HallumBuyBuyhold
Aug 14, 2025BTIGBuyBuyhold
Aug 13, 2025H.C. WainwrightBuyBuyhold
Jul 11, 2025Cantor FitzgeraldOverweightinitialise
Jun 11, 2025BTIGBuyinitialise
Apr 01, 2025B. RileyBuyBuyhold
Oct 04, 2024J.P. MorganBuyBuyhold

Financial Forecast

EPS Forecast

$-1 $0 $1 $2 $3 $4 $5 $6 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$-0.13$-0.67$-0.51$-0.75$-0.49---
Avg Forecast$-0.09$-0.48$-0.67$-0.52$-0.64$0.57$2.29$5.28
High Forecast$-0.09$-0.47$-0.66$-0.50$-0.62$0.79$3.07$5.58
Low Forecast$-0.09$-0.50$-0.70$-0.55$-0.67$0.33$1.51$5.15
Surprise %44.44%39.58%-23.88%44.23%-23.44%---

Revenue Forecast

$0 $40T $80T $120T $160T $200T Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$48.87M$72.48M$88.59M$130.19M$199.61T---
Avg Forecast$48.73M$71.64M$89.54M$131.69M$191.85M$283.47M$427.48M$704.66M
High Forecast$49.85M$73.28M$92.57M$137.39M$200.16M$295.75M$446.00M$735.18M
Low Forecast$47.61M$70.00M$88.14M$129.12M$188.11M$277.94M$419.13M$690.90M
Surprise %0.28%1.16%-1.06%-1.13%104045455.83%---

Net Income Forecast

$-50M $0 $50M $100M $150M $200M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$-3.42M$-18.01M$-14.09M$-24.41M$-17.48M---
Avg Forecast$-2.94M$-15.76M$-21.85M$-17.11M$-21.03M$21.49M$91.07M$174.88M
High Forecast$-2.85M$-15.29M$-21.41M$-16.42M$-20.19M$25.70M$100.13M$181.91M
Low Forecast$-3.02M$-16.23M$-22.82M$-17.80M$-21.88M$10.90M$49.25M$167.84M
Surprise %16.47%14.22%-35.54%42.65%-16.88%---

HROW Forecast FAQ

Is Harrow Health stock a buy?

Harrow Health stock has a consensus rating of Buy, based on 9 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 9 Buy, 0 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Harrow Health is a favorable investment for most analysts.

What is Harrow Health's price target?

Harrow Health's price target, set by 9 Wall Street analysts, averages $73 over the next 12 months. The price target range spans from $64 at the low end to $94 at the high end, suggesting a potential 42.91% change from the previous closing price of $51.08.

How does Harrow Health stock forecast compare to its benchmarks?

Harrow Health's stock forecast shows a 42.91% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the specialty & generic drug manufacturers stocks industry (20.02%).

What is the breakdown of analyst ratings for Harrow Health over the past three months?

  • December 2025: 0% Strong Buy, 100.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • November 2025: 12.50% Strong Buy, 87.50% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • October 2025: 12.50% Strong Buy, 87.50% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is Harrow Health’s EPS forecast?

Harrow Health's average annual EPS forecast for its fiscal year ending in December 2025 is $0.57, marking a -216.33% decrease from the reported $-0.49 in 2024. Estimates for the following years are $2.29 in 2026, and $5.28 in 2027.

What is Harrow Health’s revenue forecast?

Harrow Health's average annual revenue forecast for its fiscal year ending in December 2025 is $283.47M, reflecting a -100.00% decrease from the reported $199.61T in 2024. The forecast for 2026 is $427.48M, and $704.66M for 2027.

What is Harrow Health’s net income forecast?

Harrow Health's net income forecast for the fiscal year ending in December 2025 stands at $21.49M, representing a -222.94% decrease from the reported $-17.481M in 2024. Projections indicate $91.07M in 2026, and $174.88M in 2027.